Leadership Team

David Moatazedi has served as our President, Chief Executive Officer and as a member of our board of directors since May 2018. From 2016 to 2018, David served as Senior VP at Allergan, Inc., and division head of the U.S. Medical Aesthetics division, which included facial aesthetics, plastic surgery and skin care products. Prior to that, David worked in various leadership capacities within Allergan since 2005, including as VP, Sales and Marketing of the U.S. Facial Aesthetics division and VP, Sales and Marketing of the U.S. Plastic Surgery division. Before Allergan, David was a district manager at Novartis Pharmaceuticals for the Dermatology division. He holds an M.B.A. from Pepperdine University and a B.A. from California State University, Long Beach.

Lauren Silvernail has served as our Chief Financial Officer and Executive Vice President, Corporate Development since May 2018. From 2013 to 2018, Lauren served as the CFO and Executive VP, Corporate Development of Revance Therapeutics, Inc. and from 2015 to 2018 was also Chief Business Officer. From 2003 to 2012, Lauren was CFO and VP of Corporate Development at ISTA Pharmaceuticals, Inc. From 1995 to 2003, she served in various operating and corporate development positions with Allergan, Inc., including VP, Business Development. Prior to joining Allergan, Inc., Lauren worked at Glenwood Ventures, an investment firm, as a General Partner. She currently serves on the board of directors and the audit committee of Nicox S.A. Lauren holds a B.A. in Biophysics from the University of California, Berkeley and an M.B.A. from the Anderson Graduate School of Management at the University of California, Los Angeles.

Rui Avelar, M.D., has served as our Chief Medical Officer, and as the Chief Medical Officer of ALPHAEON, since January 2014. From 2011 to 2013, Rui served as Chief Medical Officer of Allergan Medical, where he was responsible for clinical development, clinical operations, safety, medical writing, biostatistics and regulatory matters. Rui holds a M.D. from the University of Toronto and has received training accreditation in Sports Medicine from the Canadian Academy of Sports Medicine.

Crystal Muilenburg has nearly two decades of experience in marketing and corporate communications & PR for mid-cap and start-up enterprises in the United States and internationally. Prior to joining Evolus in February 2019, Crystal was head of global strategic marketing at Sienna Biopharmaceuticals, a clinical-stage medical dermatology company. Prior to Sienna, Crystal spent more than a decade at Allergan, Inc., serving in various leadership positions in U.S. and international marketing and corporate communications, specifically in medical aesthetics, where she built a deep expertise in brand awareness and consumer activation strategies. Crystal earned a B.S. degree in Biology from California Polytechnic State University, San Luis Obispo.

Jeff Plumer joined Evolus in 2014 as VP, Legal and Corporate Secretary and was promoted to General Counsel in November 2020. Previously, he was a corporate attorney at K&L Gates, a fully integrated law firm located across five continents, where he worked on a wide range of legal matters including mergers and acquisitions, capital markets transactions, corporate governance issues and intellectual property transactions. Jeff received his J.D. from the University of California, Davis School of Law and his B.A. from the University of Colorado at Boulder.

Jessica Novak joined Evolus in November 2021 as Senior Vice President, Human Resources. Prior to Evolus, Jessica was Senior Vice President in charge of total rewards, organizational and talent development, and learning and culture functions at RGP, a next-generation global human capital firm. Prior to RGP, Jessica was the global head of HR and a member of the Executive Leader Team at Ambry Genetics and has additional experience in the manufacturing, pharmaceuticals, and education industries. A board member of the National Human Resource Association, Jessica earned a B.S. in Psychology and Sociology with a minor in Business Administration at the University of Oregon. She also earned her M.S. in Human Resources Management at Chapman University.

Christos Monovoukas joined Evolus in March 2022 as Senior Vice President, Corporate Development. From 2014 to 2022, Christos served as VP of Global M&A and Corporate Development at Olympus Corporation, an optical and digital precision technology manufacturer. From 2010 to 2014, he served as VP of Strategic New Business Development at Smith & Nephew, a medical equipment manufacturer. Christos was VP of New Business Development at Pharos from 2004 to 2010. He spent the first 10 years of his career in mechanical engineering before he found his passion for corporate development. He holds both a B.S. and M.S. in Mechanical Engineering from Columbia University and he later obtained his M.B.A. in General Management from Harvard University.

Kurt Knab joined Evolus in August 2018 as Vice President of Sales. Prior to Evolus, Kurt served as VP of Sales at Medline Industries, a privately held manufacturer and distributor of medical supplies. Before Medline, Kurt held multiple sales leadership roles at Lifecell Corporation culminating in VP of Sales. Kurt has more than two decades of experience in the medical and aesthetic industries. He earned his B.S. in Marketing from Pennsylvania State University.